8.75p
-2.78%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Abingdon Health
Its shares trade on LSE under the ticker ABDX.L. It has been listed since 15 December 2020. In the fiscal year to 30 June 2026, it reported revenue of £11.0m and a net loss of £2.1m. At that date it held total assets of £10.8m and shareholders' equity of £6.1m.
Abingdon Health Plc engages in the development, manufacturing, and distribution of diagnostic devices and provide consultancy services to businesses in the diagnostics sector. The company is headquartered in York, North Yorkshire. The company went IPO on 2020-12-15. The firm develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 15 Dec 2020
- Employees
- 82
- Website
- abingdonhealth.com ↗
Leadership
Pay as last reported
- Dr. Christopher HandNon-Executive Chairman of the Board£77,000
- Mr. Thomas HayesChief Financial Officer, Executive Director, since 2025
- Dr. Katie BrennerNon-Executive Independent Director
- Mrs. Mary TavenerSenior Non-Executive Independent Director£41,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Abingdon Health PLC develops diagnostic devices and provides consultancy services in the Health Care sector.
- Abingdon Simply Test offers self-tests for consumers to manage their health and wellbeing.
- The company's CDMO division supports product development and regulatory services for diagnostics.
Weaknesses
- Abingdon Health PLC has 82 employees, which is a small workforce for a sector requiring scale.
- The company's IPO on 15 December 2020 may limit its capital for expansion.
- Abingdon Health PLC's business is concentrated in diagnostic devices and consultancy services.
Opportunities
- The Abingdon Simply Test e-commerce platform can expand into new markets for self-tests.
- The CDMO division can grow by offering more regulatory support services.
- The company can leverage its segments to enter clinical and environmental testing markets.
Threats
- The Health Care sector faces increasing regulatory challenges for diagnostic devices.
- Competition in the diagnostics sector may intensify with new entrants.
- The company's small employee count could hinder its ability to meet growing demand.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.